Lexicon appoints Scott M. Coiante as CFO; base salary $450K, option for 230K shares

LEXICON PHARMACEUTICALS, INC.

Scott M. Coiante named SVP and CFO effective Jan 2, 2025; Kristen Alexander remains principal accounting officer.
Base salary $450K; annual cash bonus target 40% of base salary.
Granted option to purchase 230K shares vesting 25% after 1 year then 1/48th monthly.
Coiante previously CFO at Agile Therapeutics and Aprea Therapeutics.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Scott M. Coiante

senior vice president and chief financial officer

LXRX · LEXICON PHARMACEUTICALS, INC.

Effective: 2025-01-02
Filed: January 2, 2025, 6:59 PM ET

Effective as of January 2, 2025, Scott M. Coiante was appointed as our senior vice president and chief financial officer, in which capacity he will function as our principal financial officer.

Role change

Kristen L. Alexander

vice president, finance and accounting

LXRX · LEXICON PHARMACEUTICALS, INC.

Effective: 2025-01-02
Successor: Scott M. Coiante
Filed: January 2, 2025, 6:59 PM ET

Kristen L. Alexander, our vice president, finance and accounting, relinquished her function as our principal financial officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Scott M. Coiante was appointed as senior vice president and chief financial officer at LEXICON PHARMACEUTICALS, INC..

Action: appointed
Role: senior vice president and chief financial officer

Exact text from the filing

Effective as of January 2, 2025, Scott M. Coiante was appointed as our senior vice president and chief financial officer, in which capacity he will function as our principal financial officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.9

Kristen L. Alexander changed role as vice president, finance and accounting at LEXICON PHARMACEUTICALS, INC..

Action: relinquished
Role: vice president, finance and accounting

Exact text from the filing

Kristen L. Alexander, our vice president, finance and accounting, relinquished her function as our principal financial officer.

View on SEC.gov

LEXICON PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001062822-25-000003

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.